BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pérez-García S, Calamia V, Hermida-Gómez T, Gutiérrez-Cañas I, Carrión M, Villanueva-Romero R, Castro D, Martínez C, Juarranz Y, Blanco FJ, Gomariz RP. Proteomic Analysis of Synovial Fibroblasts and Articular Chondrocytes Co-Cultures Reveals Valuable VIP-Modulated Inflammatory and Degradative Proteins in Osteoarthritis. Int J Mol Sci 2021;22:6441. [PMID: 34208590 DOI: 10.3390/ijms22126441] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Ritelli M, Chiarelli N, Cinquina V, Zoppi N, Bertini V, Venturini M, Colombi M. RNA-Seq of Dermal Fibroblasts from Patients with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders Supports Their Categorization as a Single Entity with Involvement of Extracellular Matrix Degrading and Proinflammatory Pathomechanisms. Cells 2022;11. [PMID: 36552803 DOI: 10.3390/cells11244040] [Reference Citation Analysis]
2 Lin Q, Zhang Y, Hong W, Miao H, Dai J, Sun Y. Galangin ameliorates osteoarthritis progression by attenuating extracellular matrix degradation in chondrocytes via the activation of PRELP expression. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.175347] [Reference Citation Analysis]
3 Bradley EW. Musculoskeletal Development and Skeletal Pathophysiology's. Int J Mol Sci 2022;23:9092. [PMID: 36012354 DOI: 10.3390/ijms23169092] [Reference Citation Analysis]
4 Yu C, Li L, Liang D, Wu A, Dong Q, Jia S, Li Y, Li Y, Guo X, Zang H. Glycosaminoglycan-based injectable hydrogels with multi-functions in the alleviation of osteoarthritis. Carbohydrate Polymers 2022;290:119492. [DOI: 10.1016/j.carbpol.2022.119492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chiarelli N, Zoppi N, Venturini M, Capitanio D, Gelfi C, Ritelli M, Colombi M. Matrix Metalloproteinases Inhibition by Doxycycline Rescues Extracellular Matrix Organization and Partly Reverts Myofibroblast Differentiation in Hypermobile Ehlers-Danlos Syndrome Dermal Fibroblasts: A Potential Therapeutic Target? Cells 2021;10:3236. [PMID: 34831458 DOI: 10.3390/cells10113236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]